[COPY]
Today in Israel - and what it all means for the business community at home and abroad.
🍿 Get our coverage on Spotify, and Youtube, too. Want to join the conversation? We’re on X
Quick takes:
Real Estate and Macro: May housing transactions surged 23% YoY to 8,246 units, heavily subsidized by aggressive contractor financing while the second-hand market remains depressed.
Capital Market: Rafa Laboratories debuts on the TASE with a ₪600M institutional offer for sale; Top Gum projects a $145M annual sales run rate following a strategic rollout in Costco US; Tower Semiconductor announced a $3B capacity expansion in Japan, supported by a $1B government grant, to capture surging AI optics demand.
Real Estate and Macro
The Ministry of Finance reported a 23% YoY jump in May 2026 residential real estate transactions, totaling 8,246 units (a 63% MoM increase). However, this recovery is acutely asymmetrical. Sales of new contractor apartments skyrocketed 51% YoY, artificially propped up by sweeping financing subsidies. In Jerusalem, where contractors are sitting on a massive overhang of 10,000 unsold units, 43% of all transactions relied on developer-backed financing perks. Conversely, the secondary (second-hand) market remains severely suppressed. The data also highlighted a massive wealth transfer via the government's ‘Buyer's Price’ (Mechir Lamishtaken) lottery program: early winners are aggressively cashing out as their lock-up periods expire, recording an average real capital gain of ₪1.2M per apartment in Rishon LeZion and ₪1.01M in Lod.
Our take: The 23% transaction spike is a statistical mirage; it is engineered entirely by contractor financing schemes rather than organic consumer purchasing power. Developers, trapped with massive, illiquid inventory, are effectively operating as shadow banks—absorbing interest rate costs to move product without officially dropping headline prices. The Israeli consumer is not acting irrationally by jumping on these subsidized loans; they are captive in a system with zero portability and a structural housing deficit. Furthermore, the massive capital gains reaped by the lottery winners expose the absolute deadweight loss of government price-fixing lotteries. Rather than addressing the regulatory layering and land monopolies that restrict macro supply, the state simply transferred millions in arbitrary wealth to a randomized fraction of the public, exacerbating extreme inequality while leaving the broader market perfectly trapped.
Capital Markets
After 90 years as a private entity, Rafa Laboratories has officially transitioned to a public company, completing a ₪600M initial public offering (IPO) on the Tel Aviv Stock Exchange at a ₪1.5B valuation. Executed entirely as an offer for sale by existing shareholders, the structural offering priced at ₪158.1 per unit (comprising 10 shares and 6 options). The book-building process was fully absorbed by institutional investors, with provident and pension funds taking 59% of the allocation. The company, which generated ₪418M in revenue and a ₪100M net profit in 2025, operates a highly lucrative biodefense division, manufacturing automated emergency syringes utilized by the US military.
On the consumer health front, Top Gum (TASE: TPGM) has updated its H2 2026 forward guidance, projecting its annual sales run rate to eclipse $145M. This represents a 21% surge from the $120M run rate reported at the start of the year. The accelerated momentum is heavily anchored by an exclusive North American distribution agreement. A leading nutritional supplement client will launch a patented ‘Gummiceuticals’ formulation across Costco US wholesale locations in Q4 2026, a move expected to inject millions of dollars into Top Gum’s top line in the near term, with full macroeconomic impact materializing in 2027.
Simultaneously, Tower Semiconductor (TASE: TSEM) has unveiled a $3B strategic capacity expansion in Japan, aimed at capturing the surging global demand for Silicon Photonics and Silicon Germanium (SiGe) optical chips. The capital expenditure is heavily de-risked by a $1B non-dilutive grant from the Japanese government. The roadmap involves converting the Arai facility (Fab 6) to advanced optical packaging and expanding the 300mm Uozu facility (Fab 7), with full production slated for Q4 2027. Backed by this massive subsidy, Tower has updated its 2028 macroeconomic targets, projecting $3.6B in top-line revenue and $1.2B in net profit.
Our take: The unifying thread across Rafa’s IPO, Top Gum’s Costco arbitrage, and Tower’s Japanese expansion is a masterclass in bypassing domestic structural friction to capture global margin. Rafa’s ₪600M institutional lock relies heavily on the inelastic demand of US Department of Defense biodefense contracts, providing a defensive, high-yield anchor immune to local volatility. Top Gum demonstrates how mid-cap manufacturers can escape the Israeli retail oligopoly by exporting patented formulations directly into massive, open-border US distribution networks. Meanwhile, Tower Semiconductor is aggressively exploiting global semiconductor mercantilism. By securing a $1B sovereign capital injection from Tokyo, Tower drastically reduces its own capex burden while positioning its optics capacity directly into the AI data center boom. Ultimately, these three distinct capital events prove that when sophisticated Israeli firms are exposed to true free-market velocity and foreign capital subsidies, they scale exponentially.
TASE snapshot for Wednsday, July 15, 2026
TA-35 Index (TASE:TA35) 🟢 +2.69%
TA-90 (TASE:TA90):🟢 +2.28%
TA-125 (TASE:TA125): 🟢 +2.61%
If you enjoyed this update, forward it on.
TV10 Global | Israel for Investors
Bringing you the top stories from the Israeli business community, by Israel’s only business and finance network.
Share your thoughts with us via: global@tv10.co.il or the Newsroom WhatsApp: +972-55-994-5851.
📧 Subscribe to this newsletter! And follow the daily conversation on 𝕏 @tv10global.
Disclaimer: This brief is for informational purposes only and does not constitute investment advice. All data current as of publication date.